Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Surveillance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02675920
What this trial is testing

HCC High Risk Group Using Two Surveillance Tools

Who this might be right for
HCC
Seoul National University Hospital 139
Not applicableStudy completedNCT01012011
What this trial is testing

Regulatory Post Marketing Surveillance Study on Nexavar®

Who this might be right for
Carcinoma, HepatocellularCarcinoma, Renal Cell
Bayer 2,845
Not applicableLooking for participantsNCT06653062
What this trial is testing

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tongji Hospital 50
Not applicableLooking for participantsNCT06544629
What this trial is testing

Imjudo & Imfinzi PMS

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 246
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Not applicableLooking for participantsNCT05095714
What this trial is testing

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

Who this might be right for
Hepatocellular CarcinomaLiver CancerCirrhosis+1 more
Assistance Publique - Hôpitaux de Paris 944
Not applicableStudy completedNCT01446666
What this trial is testing

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

Who this might be right for
Cirrhosis of Liver
Asan Medical Center 423
Not applicableActive Not RecruitingNCT06635694
What this trial is testing

NaVIGation Invitations Liver surveillANce upTake

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hep B
Imperial College London 652
Not applicableUnknownNCT05286099
What this trial is testing

The Surveillance of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese PLA General Hospital 100
Not applicableActive Not RecruitingNCT07444905
What this trial is testing

Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaMachine LearningEvaluation
Tongji Hospital 1,523
Not applicableUnknownNCT04414956
What this trial is testing

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSurveillance
Korea University 1,418
Not applicableStudy completedNCT05225207
What this trial is testing

Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Who this might be right for
Liver NeoplasmsCarcinoma, Hepatocellular
Eisai Korea Inc. 658
Not applicableStudy completedNCT05100082
What this trial is testing

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Cancer
Takeda 263
Not applicableStudy completedNCT03663114
What this trial is testing

A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Eisai Inc. 713
Not applicableStudy completedNCT04248816
What this trial is testing

Hepatocellular Carcinoma Surveillance in Cirrhotics

Who this might be right for
Hepatocellular CarcinomaCirrhosis
University of Pennsylvania 615
Not applicableLooking for participantsNCT04455932
What this trial is testing

HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

Who this might be right for
Hepatocellular CarcinomaHCC
Concord Repatriation General Hospital 476
Not applicableStudy completedNCT01361061
What this trial is testing

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

Who this might be right for
Liver Cirrhosis
University Hospital Freiburg 450
Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Not applicableUnknownNCT03588442
What this trial is testing

Prospective Surveillance for Very Early Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Eastern Hepatobiliary Surgery Hospital 10,000
Not applicableActive Not RecruitingNCT05756699
What this trial is testing

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Who this might be right for
Liver Cirrhosis
Seoul National University Hospital 200
Next Page